Selected publications from PubMed
Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
Yue D, Huang M, Song P, Chen Y, Li B, Fu J, Guo J, Cheng C, Chen Q, Xu S, Liu H, Lv F, Hu J, Jiang K, Mao W, Shen B, Ye F, Li J, Zhang X, Guo S, Yu B, Zhu Y, Wu M, Zheng W, Chen F, He Z, Bai Y, Xin H, Chen K, Mao N, Zhang Y, Wang B, Zhang L, Chen X, Mei X, Miao L, Wang R, Li G, Yao J, Zhao J, Chen C, Liu J, Wei L, Yan X, Jin B, Liu X, Liu Z, Tian H, Xing W, Yang L, Ge D, Li X, Li S, Song Y, Zang A, Zhang D, Zhuang W, Liu Z, Yuan X, Fu T, Shen Z, Zhang X, Cao Q, Zhao L, Mao L, Ding L, Lu Y, Wang C, ELEVATE Study Group
N Engl J Med. 2026 Jul 9;395(2):151-161 doi: 10.1056/NEJMoa2518990.
The Role of hs-CRP and Systemic Immune-Inflammation Index in Sarcopenia and Sarcopenic Obesity in Young Populations: Results from the National Health and Nutrition Examination Survey 2015-2018.
Ge D, Yu Y, Rao J, Ren H, Wang Z, Zhang B
Endocr Metab Immune Disord Drug Targets. 2026;26:e18715303440752 doi: 10.2174/0118715303440752251229094023.
Isoliquiritigenin combined with gemcitabine inhibited lung cancer by suppressing JAK2/STAT3 signaling via lncRNA-p21/miRNA-4534 axis.
Xu C, Gong C, Wang C, Xie M, Wu M, Ge D, Ren H, Zhang B, Jiang Z, Li W
J Nat Med. 2026 May;80(3):583-602 doi: 10.1007/s11418-025-01990-8.
Combined inflammatory-lipid index and tumor markers for predicting the spatial localization of lesions in early-stage non-small cell lung cancer.
Yang Z, Zhao S, Cheng Z, Ge D, Ren H, Xu J, Zhang B
Front Oncol. 2025;15:1635315 doi: 10.3389/fonc.2025.1635315.
STC2 regulates the proliferation, migration and glycolysis of glioma cells through modulating ITGB2.
Wei Z, Ge D, Bu J, Wang X, Zhong T, Gongye X, Zhang B, Yan F, He C, Guo R, Li J, Jin Z
Metab Brain Dis. 2025 Mar 24;40(4):156 doi: 10.1007/s11011-025-01571-4.
Help your network discover Dr. Di Ge's clinical expertise.
